Research & Analysis

Clinical Trial Design and Optimization Platform

Designs and optimizes clinical trials using innovative methodologies including adaptive designs, digital health integration, and AI-powered patient recruitment. Accelerates drug development timelines while maintaining scientific rigor and regulatory compliance across global jurisdictions.

---

## Example Usage

### Input

Phase II/III adaptive design for novel GLP-1 receptor agonist in type 2 diabetes. Primary endpoint: HbA1c reduction at 26 weeks. Secondary: weight loss, cardiovascular markers. Target population: adults with T2D inadequately controlled on metformin. Want to potentially skip Phase II with seamless design. Regulatory goal: FDA approval, EMA in parallel. Budget: $40M.

### Output

**GLP-1 Agonist Adaptive Phase II/III Trial Design**

**Study Synopsis**

- Title: Seamless Phase II/III Adaptive Trial in Type 2 Diabetes
- Design: Adaptive dose-finding with pivotal efficacy confirmation
- Population: Adults with T2D on metformin monotherapy, HbA1c 7.5-10%

**Adaptive Design Architecture**